Compare MobilEye Global Inc (MBLY) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MobilEye Global Inc vs Altria Group Inc — how do they compare? MobilEye Global Inc trades at $7.1 (market cap $6.00B), while Altria Group Inc trades at $71.39 (market cap $119.25B). The key difference: Altria Group Inc is far larger — about 19.9× MobilEye Global Inc's market cap, and Altria Group Inc pays a 6.22% dividend while MobilEye Global Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold MobilEye Global Inc for 15 Days and Altria Group Inc for 154 Days on average.
| MBLY | MO | |
|---|---|---|
Market Cap | $6.00B | $119.25B |
Volume | 7,007,849 | 11,178,169 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $15.42 | $74.92 |
52-Week Low | $6.56 | $54.72 |
Typical Hold Time | 15 Days | 154 Days |
Enterprise Value | $4.56B | $141.46B |
Dividend Yield | — | 6.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mobileye Global (MBLY) trades at $7.15, down 4.28% amid bearish technical signals, though RSI levels suggest potential oversold conditions. The company shows mixed fundamentals with strong revenue growth to $2.0B in 2026 but deep losses (-$4.1B net income). Analyst consensus remains positive with 57.7% buy ratings and $10.83 price target, while recent news highlights ADAS business momentum and autonomous vehicle expansion initiatives.
MBLY presents a high-risk opportunity with significant upside potential if execution improves, but current profitability challenges and bearish technicals warrant caution. The stock trades below book value (P/B 0.74) with institutional confidence shown through recent insider buying, though competitive pressures in autonomous driving and ongoing losses represent substantial investor risks.
Altria Group (MO) trades at $69.39, up 1.22% today, with a bullish technical signal from moving averages. The stock shows strong profitability with a 39% net income margin and a 6.6% dividend yield, though recent earnings have been mixed with two misses in the last four quarters. Cash flow improved in 2025 with net cash flow of $1.33 billion, but the balance sheet carries negative equity of -$2.24 billion due to high liabilities.
The outlook is balanced: analyst consensus is bullish with a $69.71 price target, but risks include regulatory pressures on tobacco, declining margins, and high debt. The dividend appears sustainable from cash flow, yet negative equity and business shrinkage pose long-term concerns for income-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
